Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

2 Oct 2012 17:08

null

Tate & Lyle PLC

Transaction in Own Shares

Tate & Lyle PLC (the "Company") announces that on 2 October 2012 it transferred at nil cost 40,533 ordinary shares in the Company for the purpose of satisfying exercises under the Tate & Lyle 2003 Performance Share Plan. These shares were previously held in Treasury.

Following the above transfer, the Company holds 1,998,261 ordinary shares in Treasury and has 466,170,559 ordinary shares in issue (excluding Treasury shares).

Lucie GilbertCompany Secretary2 October 2012

Copyright Business Wire 2012

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.